Antagonistic Activity of Ascorbic Acid (Vitamin C) on Dopaminergic Modulation: Apomorphine-Induced Stereotypic Behavior in Mice
Authors:
- Ashish DhirADAshish Dhir
- S.K. KulkarniSKS.K. Kulkarni
- 1 May 2006
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 77 (1) , 38-45
Abstract
Among the various neurotransmitter systems implicated in the mechanism of action of ascorbic acid (vitamin C), the relationship between the dopaminergic system and ascorbic acid is not particularly clear. Ascorbic acid is speculated to have an antagonistic effect on dopaminergic modulation. With this background in mind, in the present study we have seen the effect of ascorbic acid per se and in combination with typical and atypical antipsychotic agents against apomorphine-induced stereotypic behavior in mice. Male Laka mice weighing 20–25 g were used in the present study. Apomorphine-induced stereotypic behavior was used as an animal model. Various dopaminergic modulators were used. Ascorbic acid dose-dependently inhibited stereotypic behavior produced by apomorphine in mice. It potentiated the antipsychotic activity of haloperidol (0.1 mg/kg i.p.), a typical antipsychotic agent. When administered along with atypical antipsychotics, clozapine (1–2 mg/kg i.p.), sulpiride (10–20 mg/kg i.p.) and risperidone (0.0025 mg/kg i.p.), ascorbic acid also potentiated their activity. Also when given along with SCH-23390, a selective D1 antagonist, an additive effect was observed. Ascorbic acid also inhibited the supersensitization response of apomorphine on reserpinization (2 mg/kg i.p.). Interestingly, at a lower dose (100 mg/kg i.p.), ascorbic acid potentiated the dopaminergic activity of apomorphine (0.5 mg/kg) and BHT-920 (0.25 mg/kg i.p.). However, when given concomitantly with SKF-38393, it failed to alter the response of SKF-38393. The data substantiate the hypothesis that ascorbic acid potentiated the activity of typical as well as atypical antipsychotics and that the effect of ascorbic acid on the dopaminergic system is markedly dose dependent; a low dose (100 mg/kg i.p.) potentiated the dopaminergic action while higher doses (400–1,600 mg/kg i.p.) blocked it.Keywords
This publication has 26 references indexed in Scilit:
- Dopamine D4 receptor subtypes and response to clozapineThe Lancet, 1993
- Vitamin C in the Treatment of SchizophreniaInternational Journal of Neuroscience, 1993
- Stereospecific effects of ascorbic acid and analogues on D1 and D2 agonist bindingLife Sciences, 1992
- Nitric oxide as a neuronal messengerTrends in Pharmacological Sciences, 1991
- Ascorbic Acid Inhibits [3H]sch-23390 Binding to Striatal Dopamine D1ReceptorsJournal of Receptor Research, 1989
- Ascorbic Acid and the Behavioral Response to Haloperidol: Implications for the Action of Antipsychotic DrugsScience, 1985
- Ascorbic acid and the binding of DA agonists to neostriatal membrane preparationsNeuropharmacology, 1983
- Dehydroascorbic Acid1982
- Effect of ascorbic acid on neurochemical, behavioral, and physiological systems mediated by catecholaminesLife Sciences, 1979
- LIPID PEROXIDE FORMATION IN RAT BRAINJournal of Neurochemistry, 1971